Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA

Vikas Chandra1, Pengxiang Huang, Yoshitomo Hamuro

  • 1Department of Pharmacology, and Center for Molecular Design, University of Virginia Health System, 1300 Jefferson Park Avenue, Charlottesville, Virginia 22908-0735, USA.

Nature
|December 2, 2008
PubMed

Insights

This study reveals how intact peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and retinoid X receptor-alpha (RXR-alpha) heterodimers bind DNA and ligands. The PPAR-gamma ligand-binding domain cooperates with DNA-binding domains to enhance gene regulation.

Area of Science:

  • Molecular Biology
  • Structural Biology
  • Genetics

Background:

  • Nuclear receptors are transcription factors regulating gene expression.
  • Peroxisome proliferator-activated receptors (PPARs) heterodimerize with retinoid X receptors (RXRs).
  • PPAR-gamma is a drug target linked to insulin sensitization, but its domain cooperation is poorly understood.

Purpose of the Study:

  • To elucidate the structural basis of intact PPAR-gamma/RXR-alpha heterodimer function.
  • To understand how multiple receptor domains cooperate in DNA and ligand binding.
  • To provide insights into PPAR-gamma's role in insulin sensitization.

Main Methods:

  • X-ray crystallography was used to determine the structures of intact PPAR-gamma and RXR-alpha heterodimers.
  • The structures were determined in complex with DNA response elements, ligands, and coactivator peptides.

Main Results:

  • The intact PPAR-gamma/RXR-alpha heterodimer forms a non-symmetric complex.
  • Three interfaces link PPAR-gamma and RXR-alpha, with some being DNA-dependent.
  • The PPAR-gamma ligand-binding domain (LBD) interacts with both DNA-binding domains (DBDs) to enhance DNA binding.
  • The A/B segments of the receptors are highly dynamic and lack stable structures.

Conclusions:

  • The structural data reveals a novel mechanism of receptor-DNA interaction involving domain cooperation.
  • Understanding these interactions is crucial for developing targeted therapies for metabolic diseases.
  • The dynamic nature of A/B segments despite their functional importance warrants further investigation.

Related Concept Videos

Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
6.0K
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
4.4K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
6.7K